Related Experiment Video

Updated: Feb 7, 2026

Ex Vivo Treatment Response of Primary Tumors and/or Associated Metastases for Preclinical and Clinical Development of Therapeutics
08:29

Ex Vivo Treatment Response of Primary Tumors and/or Associated Metastases for Preclinical and Clinical Development of Therapeutics

Published on: October 2, 2014

15.2K

Development of a novel conjugatable sunitinib analogue validated through in vitro and in vivo preclinical settings

Mohamed A El Mubarak1, Iliana Leontari1, Giannopoulou Efstathia2

  • 1Department of Pharmacy, Laboratory of Pharmacokinetics, University of Patras, Patras, Greece.

Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|July 17, 2018
PubMed

Insights

A novel sunitinib derivative, SB1, was developed for enhanced tumor targeting. SB1 demonstrates comparable antiproliferative effects, in vitro stability, and pharmacokinetics to sunitinib in preclinical models.

Area of Science:

  • Oncology
  • Medicinal Chemistry
  • Pharmacology

Background:

  • Sunitinib is an FDA/EMEA approved multi-targeted tyrosine kinase inhibitor with anti-angiogenic and antitumor activity.
  • Its chemical structure limits conjugation to tumor-homing moieties for improved efficacy.
  • There is a need for sunitinib derivatives that can be linked to targeting elements.

Purpose of the Study:

  • To design and synthesize a novel, linkable sunitinib derivative (SB1).
  • To evaluate the pharmaceutical profile of SB1 in vitro and in vivo.
  • To assess SB1's antiproliferative effects, stability, and pharmacokinetic properties compared to sunitinib.

Main Methods:

  • Chemical characterization using mass spectrometry and NMR spectroscopy.
  • In vitro antiproliferative assessment via MTT assays in glioma cells.
  • In vitro stability in mouse plasma and pharmacokinetic studies after intravenous administration in Balb/c mice.
  • Development and validation of a novel LC-MS/MS bioanalytical method for SB1 quantification.

Main Results:

  • SB1 was successfully synthesized and characterized.
  • SB1 exhibited preserved antiproliferative effects comparable to sunitinib in three glioma cell lines.
  • SB1 demonstrated in vitro stability in mouse plasma over 24 hours.
  • SB1 and sunitinib showed bioequivalent pharmacokinetic profiles after intravenous administration in Balb/c mice.

Conclusions:

  • A novel, linkable sunitinib analog (SB1) was successfully formulated.
  • SB1 retains the antiproliferative and apoptotic properties of sunitinib against glioma cells.
  • SB1 exhibits favorable in vitro stability and pharmacokinetic characteristics, supporting its potential for targeted drug delivery systems.
Keywords:
Analytical methodologyIn vitro cytotoxicityIn vivo pharmacokineticsSunitinibSunitinib conjugatable analogue

More Related Videos

3D Printing of Preclinical X-ray Computed Tomographic Data Sets11:06

3D Printing of Preclinical X-ray Computed Tomographic Data Sets

Published on: March 22, 2013

41.0K
Validation of Nanobody and Antibody Based In Vivo Tumor Xenograft NIRF-imaging Experiments in Mice Using Ex Vivo Flow Cytometry and Microscopy08:09

Validation of Nanobody and Antibody Based In Vivo Tumor Xenograft NIRF-imaging Experiments in Mice Using Ex Vivo Flow Cytometry and Microscopy

Published on: April 6, 2015

12.1K

Related Concept Videos

Preclinical Development: Overview01:28

Preclinical Development: Overview

Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
6.0K
In Vitro Drug Release Testing: Overview, Development and Validation01:10

In Vitro Drug Release Testing: Overview, Development and Validation

In vitro dissolution and drug release tests assess how quickly and how much of a drug is released from its dosage form into an aqueous medium under standardized laboratory conditions. These tests are essential tools in pharmaceutical development and quality assurance, offering insight into the drug's performance before clinical use.During formulation development, dissolution testing identifies incomplete or inconsistent drug release issues. It also supports decisions on selecting the optimal...
363
Reliability and Validity01:29

Reliability and Validity

Reliability and validity are two important considerations that must be made with any type of data collection. Reliability refers to the ability to consistently produce a given result. In the context of psychological research, this would mean that any instruments or tools used to collect data do so in consistent, reproducible ways.
14.1K
Equivalence: In Vitro and In Vivo Bioequivalence01:17

Equivalence: In Vitro and In Vivo Bioequivalence

Body:Bioequivalence studies are crucial in evaluating whether new drugs can match an approved one regarding pharmacological effects and clinical performance. These studies test if drugs, despite different dosage forms, share identical plasma concentration-time profiles. Three types of equivalence are central to these studies: chemical, pharmaceutical, and therapeutic. Chemical equivalence indicates that two or more drug products contain identical active ingredients in equal amounts.
236
Data Validation01:15

Data Validation

Method validation is a crucial process in analytical chemistry designed to confirm that a given method consistently produces reliable and high-quality results. This process is essential when a method is applied to different sample matrices or when procedural modifications are made, ensuring that the results meet acceptable standards across various applications.
Key parameters for method validation include:
2.1K
Data Validation01:03

Data Validation

Data validation is an essential part of a comprehensive assessment. Validation is confirming or verifying and opening the door to gathering more assessment data as it clarifies vague or unclear data. The process of checking and verifying the collected information is called data validation. The primary purpose of data validation is to ensure data is as free from error, bias, and misinterpretation as possible.
Nursing assessment guides are generally based on holistic models rather than medical...
6.8K